Public EUDAMED Search

EUDAMED Device Search

A readable public search layer for EUDAMED device, manufacturer, UDI, EMDN and risk class data.

Last updated

22.09.2026 01:15

Sync status

Successful

Device

3428095

Actor

47673

Certificate

3311

Active filter:EMDN:G04

1000+ device results listed.

Page 9 / 50

Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107040
Basic UDI-DI
42517781MD339D8
Reference
306574308
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107057
Basic UDI-DI
42517781MD339D8
Reference
306574391
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107064
Basic UDI-DI
42517781MD339D8
Reference
306574373
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107071
Basic UDI-DI
42517781MD339D8
Reference
319571308
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107088
Basic UDI-DI
42517781MD339D8
Reference
319571391
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107095
Basic UDI-DI
42517781MD339D8
Reference
319571373
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107101
Basic UDI-DI
42517781MD339D8
Reference
307572308
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107118
Basic UDI-DI
42517781MD339D8
Reference
307572391
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107125
Basic UDI-DI
42517781MD339D8
Reference
307572373
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107132
Basic UDI-DI
42517781MD339D8
Reference
307573308
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107149
Basic UDI-DI
42517781MD339D8
Reference
307573391
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107156
Basic UDI-DI
42517781MD339D8
Reference
307573373
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107163
Basic UDI-DI
42517781MD339D8
Reference
307574308
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107170
Basic UDI-DI
42517781MD339D8
Reference
307574391
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107187
Basic UDI-DI
42517781MD339D8
Reference
307574373
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107194
Basic UDI-DI
42517781MD339D8
Reference
320571308
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107200
Basic UDI-DI
42517781MD339D8
Reference
320571391
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107217
Basic UDI-DI
42517781MD339D8
Reference
320571373
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107224
Basic UDI-DI
42517781MD339D8
Reference
308572308
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29
Class IIIMDR 2017/745On the marketSingle use
Manufacturer
HÄLSA Pharma GmbH
Manufacturer SRN
DE-MF-000007407
UDI-DI
04251778107231
Basic UDI-DI
42517781MD339D8
Reference
308572391
EMDN
G0401
EMDN description
ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS
First on market country
-
Safety summary (SSCP/SSP)
SSCP_SCHW_Reflu_MD339 · Rev. 1
Authorised representative
-
Last updated
30.07.2026 02:29